Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;29(2):148-156.
doi: 10.1038/s41370-018-0097-y. Epub 2018 Nov 27.

Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence

Affiliations
Review

Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence

Jamie C DeWitt et al. J Expo Sci Environ Epidemiol. 2019 Mar.

Abstract

In this perspective, we evaluate key and emerging epidemiological and toxicological data concerning immunotoxicity of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) and seek to reconcile conflicting conclusions from two reviews published in 2016. We summarize ways that immunosuppression and immunoenhancement are defined and explain how specific outcomes are used to evaluate immunotoxicity in humans and experimental animals. We observe that different approaches to defining immunotoxicological outcomes, particularly those that do not produce clinical disease, may lead to different conclusions from epidemiological and toxicological studies. The fundamental point that we make is that aspects of epidemiological studies considered as limitations can be minimized when data from toxicological studies support epidemiological findings. Taken together, we find that results of epidemiological studies, supported by findings from toxicological studies, provide strong evidence that humans exposed to PFOA and PFOS are at risk for immunosuppression.

Keywords: Emerging contaminants; Perfluorinated chemicals; Population-based studies.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Dr. DeWitt reports that she was a protocol reviewer and a draft report reviewer for the NTP Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid or Perfluorooctane Sulfonate.

Figures

Figure 1.
Figure 1.
Serum PFOA and PFOS concentrations in epidemiological studies showing inhibited antibody responses to vaccines. (21): PFAS measured in serum of five-year-old children and antibodies measured in seven-year-old children (N=464) in the Faroe Islands; (23): PFAS measured in maternal serum at birth and antibodies measured in three-year-old children (N=56) in Norway; (24): PFAS measured in adults (N=403) from the C8 Health Project and antibodies measured after 21±3 days after vaccination; (25): PFAS measured in adults (N=1,191) in the National Health and Nutrition Examination Survey in the U.S. and antibodies to childhood vaccinations.
Figure 2.
Figure 2.
Factors used by the U.S. National Toxicology Program in assessing confidence in the body of evidence concerning the immunotoxic effects of PFOA and PFOS (adopted from 8).

References

    1. Science Advisory Board (SAB). SAB Review of EPA’s Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. 2006.
    1. Yang Q, Xie Y, Depierre JW. Effects of peroxisome proliferators on the thymus and spleen of mice. Clin Exp Immunol. 2000;122(2):219–26. - PMC - PubMed
    1. Yang Q, Xie Y, Eriksson AM, Nelson BD, DePierre JW. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem Pharmacol. 2001;62(8):1133–40. - PubMed
    1. Yang Q, Abedi-Valugerdi M, Xie Y, Zhao X-YY, Möller G, Dean Nelson B, et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol. 2002;2(2–3):389–97. - PubMed
    1. Organisation for Economic Cooperation and Development (OECD). Toward a New Comprehensive Global Database of Per- and Polyfluoroalkyl Substances (PFASs): Summary Report on Updating the OECD 2007 List of Per- and Polyfluoroalkyl Substances (PFASs). 2018. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV....

Publication types